Cornerstone Advisors, LLC Pfizer Inc Transaction History

Cornerstone Advisors, LLC

$2.51 Billion
Q3 2024

A detailed history of Cornerstone Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cornerstone Advisors, LLC holds 247,400 shares of PFE stock, worth $6.61 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

247,400

Previous 247,400 -0.0%

Holding current value

$6.61 Million

Previous $6.92 Million 3.42%

% of portfolio

0.28%

Previous 0.28%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$25.26 - $29.6 $10,104 - $11,840	-400 Reduced 0.16%	247,400 $6.92 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $137,217 - $157,569	5,300 Added 2.19%	247,800 $6.88 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $517,374 - $672,012	-19,800 Reduced 7.55%	242,500 $6.98 Million
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $628,964 - $735,196	19,600 Added 8.08%	262,300 $8.7 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $7.33 Million - $8.48 Million	202,900 Added 509.8%	242,700 $8.9 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $19.4 Million - $25.3 Million	-465,000 Reduced 92.12%	39,800 $2.04 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $4.14 Million - $5.06 Million	94,700 Added 23.09%	504,800 $22.1 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $19.1 Million - $22.6 Million	410,100 New	410,100 $21.5 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $7.2 Million - $9.15 Million	-215,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $476,250 - $558,750	-15,000 Reduced 6.52%	215,000 $7.89 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $513,570 - $733,780	-19,000 Reduced 7.63%	230,000 $7.51 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $8.2 Million - $9.3 Million	249,000 New	249,000 $9.76 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Advisors, LLC with notifications on news.

Account

Cornerstone Advisors, LLC Pfizer Inc Transaction History